Background Investigation Methods, Corporate Intelligence & Due Diligence, e-Discovery Techniques, Investigation & Intelligence Feeds, Judgment Enforcement, Legal Enforcement Cases, Legal Ethics & Intelligence, Legal Technology & Intelligence, Witness Credibility Analysis

Xbrane Enters into Conditional Financing Deal Related to Ranibizumab Biosimilar

Posted by author-avatar
0
Test Logo Transparent

As we have previously reported, on June 21, 2023, the FDA accepted Xbrane’s sBLA for LUCAMZI, a proposed ranibizumab biosimilar to Genentech’s LUCENTIS (ranibizumab)….
By: Goodwin

Newer
PTAB Grants Institution of Four PGRs related to Merck’s Keytruda Qlex™
Back to list
Older New York State attorney general discovers firm had two data breaches

Leave a Reply

Your email address will not be published. Required fields are marked *